These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 22095746)

  • 21. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-tensor imaging and voxel-based morphometry study.
    Scherfler C; Frauscher B; Schocke M; Iranzo A; Gschliesser V; Seppi K; Santamaria J; Tolosa E; Högl B; Poewe W;
    Ann Neurol; 2011 Feb; 69(2):400-7. PubMed ID: 21387382
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.
    Chen BT; Sethi SK; Jin T; Patel SK; Ye N; Sun CL; Rockne RC; Haacke EM; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Somlo G; Li D; Yang R; Tan H; Katheria V; Morrison R; Hurria A
    Breast Cancer Res; 2018 May; 20(1):38. PubMed ID: 29720224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combined analysis of grey matter voxel-based morphometry and white matter tract-based spatial statistics in late-life bipolar disorder.
    Haller S; Xekardaki A; Delaloye C; Canuto A; Lövblad KO; Gold G; Giannakopoulos P
    J Psychiatry Neurosci; 2011 Nov; 36(6):391-401. PubMed ID: 21284917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late effects of adjuvant chemotherapy for breast cancer on fine motor function.
    Hoogendam YY; Schagen SB; Ikram MA; Boogerd W; Seynaeve C; Seidler RD; Breteler MM; Van der Geest JN; Koppelmans V
    Psychooncology; 2015 Dec; 24(12):1799-807. PubMed ID: 25756497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Rosenbrand RM; van Rhijn D; Rodenhuis S; van Dam FS
    Ann Oncol; 2002 Sep; 13(9):1387-97. PubMed ID: 12196364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing spatial relationships between axonal integrity, regional brain volumes, and neuropsychological outcomes after traumatic axonal injury.
    Warner MA; Marquez de la Plata C; Spence J; Wang JY; Harper C; Moore C; Devous M; Diaz-Arrastia R
    J Neurotrauma; 2010 Dec; 27(12):2121-30. PubMed ID: 20874032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer.
    Chen BT; Jin T; Patel SK; Ye N; Sun CL; Ma H; Rockne RC; Root JC; Saykin AJ; Ahles TA; Holodny AI; Prakash N; Mortimer J; Waisman J; Yuan Y; Li D; Somlo G; Vazquez J; Levi A; Tan H; Yang R; Katheria V; Hurria A
    Breast Cancer Res Treat; 2018 Nov; 172(2):363-370. PubMed ID: 30088178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural brain abnormalities in women with subclinical depression, as revealed by voxel-based morphometry and diffusion tensor imaging.
    Hayakawa YK; Sasaki H; Takao H; Mori H; Hayashi N; Kunimatsu A; Aoki S; Ohtomo K
    J Affect Disord; 2013 Jan; 144(3):263-8. PubMed ID: 23141669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential vulnerability of gray matter and white matter to intrauterine growth restriction in preterm infants at 12 months corrected age.
    Padilla N; Junqué C; Figueras F; Sanz-Cortes M; Bargalló N; Arranz A; Donaire A; Figueras J; Gratacos E
    Brain Res; 2014 Jan; 1545():1-11. PubMed ID: 24361462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
    Bergh J; Wiklund T; Erikstein B; Lidbrink E; Lindman H; Malmström P; Kellokumpu-Lehtinen P; Bengtsson NO; Söderlund G; Anker G; Wist E; Ottosson S; Salminen E; Ljungman P; Holte H; Nilsson J; Blomqvist C; Wilking N
    Lancet; 2000 Oct; 356(9239):1384-91. PubMed ID: 11052580
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen.
    Castellon SA; Ganz PA; Bower JE; Petersen L; Abraham L; Greendale GA
    J Clin Exp Neuropsychol; 2004 Oct; 26(7):955-69. PubMed ID: 15742545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study.
    McDonald BC; Conroy SK; Smith DJ; West JD; Saykin AJ
    Brain Behav Immun; 2013 Mar; 30 Suppl(0):S117-25. PubMed ID: 22613170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study.
    Kreukels BP; Schagen SB; Ridderinkhof KR; Boogerd W; Hamburger HL; Muller MJ; van Dam FS
    Clin Breast Cancer; 2006 Apr; 7(1):67-78. PubMed ID: 16764746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-induced structural changes in cerebral white matter and its correlation with impaired cognitive functioning in breast cancer patients.
    Deprez S; Amant F; Yigit R; Porke K; Verhoeven J; Van den Stock J; Smeets A; Christiaens MR; Leemans A; Van Hecke W; Vandenberghe J; Vandenbulcke M; Sunaert S
    Hum Brain Mapp; 2011 Mar; 32(3):480-93. PubMed ID: 20725909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural brain differences and cognitive functioning related to body mass index in older females.
    Walther K; Birdsill AC; Glisky EL; Ryan L
    Hum Brain Mapp; 2010 Jul; 31(7):1052-64. PubMed ID: 19998366
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with chemotherapy: a longitudinal analysis.
    Cheung YT; Sabin ND; Reddick WE; Bhojwani D; Liu W; Brinkman TM; Glass JO; Hwang SN; Srivastava D; Pui CH; Robison LL; Hudson MM; Krull KR
    Lancet Haematol; 2016 Oct; 3(10):e456-e466. PubMed ID: 27658980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated aging, decreased white matter integrity, and associated neuropsychological dysfunction 25 years after pediatric lymphoid malignancies.
    Schuitema I; Deprez S; Van Hecke W; Daams M; Uyttebroeck A; Sunaert S; Barkhof F; van Dulmen-den Broeder E; van der Pal HJ; van den Bos C; Veerman AJ; de Sonneville LM
    J Clin Oncol; 2013 Sep; 31(27):3378-88. PubMed ID: 23960182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer.
    de Ruiter MB; Reneman L; Boogerd W; Veltman DJ; van Dam FS; Nederveen AJ; Boven E; Schagen SB
    Hum Brain Mapp; 2011 Aug; 32(8):1206-19. PubMed ID: 20669165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1H MR spectroscopy of gray and white matter in carbon monoxide poisoning.
    Kondziella D; Danielsen ER; Hansen K; Thomsen C; Jansen EC; Arlien-Soeborg P
    J Neurol; 2009 Jun; 256(6):970-9. PubMed ID: 19252780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study.
    Dodd JW; Chung AW; van den Broek MD; Barrick TR; Charlton RA; Jones PW
    Am J Respir Crit Care Med; 2012 Aug; 186(3):240-5. PubMed ID: 22652026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.